In the current study, we found that systemic administration of allogeneic NK cells significantly attenuated TGF-β expression in tumor mass, suggesting that allogeneic NK cells may attenuate immunosuppressive burden in the tumor milieu (Figure 7). Here, TGFB1 is linked to neoplasm.